Breaking Down Accolade: 8 Analysts Share Their Views

BenzingaDec 18 03:00

Accolade Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesDec 18 00:56 · Ratings

Morgan Stanley Maintains Accolade(ACCD.US) With Hold Rating, Cuts Target Price to $5

Futu NewsDec 17 22:31 · Ratings

FDA Roundup: December 17, 2024

US FDADec 17 08:00

Accolade to Announce Fiscal Third Quarter 2025 Financial Results

Accolade Dec 16 13:00

Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler

Seeking AlphaDec 4 02:52